SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-23-001493
Filing Date
2023-11-14
Accepted
2023-11-14 16:10:46
Documents
13
Period of Report
2023-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e619057_8k-arct.htm   iXBRL 8-K 26784
2 e619057_ex99-1.htm EX-99.1 100322
  Complete submission text file 0001193805-23-001493.txt   316869

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE arct-20231114.xsd EX-101.SCH 3021
4 XBRL LABEL FILE arct-20231114_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE arct-20231114_pre.xml EX-101.PRE 22363
7 EXTRACTED XBRL INSTANCE DOCUMENT e619057_8k-arct_htm.xml XML 3446
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 231406214
SIC: 2834 Pharmaceutical Preparations